Foamix Pharmaceuticals Ltd. 3 SEC Filings

Filed On	Filing
06 Aug 2019	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 11,203,881 shares of Common Stock
28 Jan 2019	Form 3: Barbari Sharon Surrey, Director No securities owned
26 Nov 2018	Form 3: Wiley Matthew T., Chief Commercial Officer No securities owned
26 Nov 2018	Form 3: Bruno Anthony D, Director Holds 41,500 shares of Ordinary Shares
18 Jan 2018	Form 3: Eini Meir, Observer to Board of Directors Holds 2,757,781 shares of Ordinary Shares
11 Jan 2018	Form 3: Hazot Yohan, VP Pharmaceutical Development Holds 6,184 shares of Ordinary Shares
11 Jan 2018	Form 3: Hadar Ilan, Country Manager and CFO Holds 7,277 shares of Ordinary Shares
11 Jan 2018	Form 3: Schuz David, VP IP Holds 6,184 shares of Ordinary Shares
11 Jan 2018	Form 3: Hirsch Stanley, Director Holds 6,448 shares of Ordinary Shares
11 Jan 2018	Form 3: Shirvan Mitchell, VP Innovation & Discovery Holds 6,184 shares of Ordinary Shares
11 Jan 2018	Form 3: Howard Alvin D, VP Regulatory Holds 18,390 shares of Ordinary Shares
11 Jan 2018	Form 3: Tamarkin Dov, Director Holds 2,563,489 shares of Ordinary Shares
11 Jan 2018	Form 3: Domzalski David, CEO Holds 23,192 shares of Ordinary Shares
11 Jan 2018	Form 3: Bright Rex, Director
11 Jan 2018	Form 3: Stuart Iain, SVP R&D
11 Jan 2018	Form 3: Stern Stanley, Director
11 Jan 2018	Form 3: Schwartz Aharon, Director
11 Jan 2018	Form 3: Rigel Darrell S, Director
11 Jan 2018	Form 3: Pappacena Bonnie, VP Quality
11 Jan 2018	Form 3: Harsch Mutya, General Counsel and SVP Legal No securities owned

Comments